Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
3.495
-0.055 (-1.56%)
At close: May 13, 2025, 4:00 PM
3.800
+0.305 (8.74%)
Pre-market: May 14, 2025, 8:00 AM EDT
Biomerica Employees
Biomerica had 64 employees as of May 31, 2024. The number of employees increased by 2 or 3.23% compared to the previous year.
Employees
64
Change (1Y)
2
Growth (1Y)
3.23%
Revenue / Employee
$88,719
Profits / Employee
-$75,781
Market Cap
8.90M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BMRA News
- 7 days ago - PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement - GlobeNewsWire
- 21 days ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection - GlobeNewsWire
- 27 days ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - GlobeNewsWire
- 4 weeks ago - Biomerica Announces Reverse Stock Split - GlobeNewsWire
- 2 months ago - Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis - GlobeNewsWire
- 2 months ago - Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal - GlobeNewsWire
- 4 months ago - Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval - Benzinga
- 4 months ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer - GlobeNewsWire